RVMD Officer Files Intent to Sell $235K in Company Stock
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
RVMD Officer Files Intent to Sell $235K in Company Stock
Company: Revolution Medicines, Inc. (RVMD) Form: 144 | Filed: 2025-12-12 Significance: Low
Insider: Anders Jack Title: Officer | Relationship: Officer
Transaction (Proposed): • Type: Proposed Sale • Shares: 3,017 • Est. Value: $234,752.77 • Approx. Date: 2025-12-15
Key Insight: This is a routine, low-value proposed sale representing a negligible fraction (0.0018%) of the company's market cap. The sale is part of a pre-arranged 10b5-1 trading plan.
Market Context: Revolution Medicines has a market capitalization of $13.10 billion. This transaction is immaterial in size and part of a consistent pattern of sales by the insider.
Comprehensive Analysis
SEC Filing Analysis: Revolution Medicines, Inc. (RVMD)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer at Revolution Medicines has filed a notice of a proposed sale of common stock valued at approximately $234,753.
- Market Impact: The transaction is negligible relative to the company's market capitalization and is not expected to have any market impact.
Company Information
| Field | Value |
|---|---|
| Company | Revolution Medicines, Inc. |
| Ticker Symbol | RVMD |
| CIK | 0001628171 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Anders Jack |
| CIK | 0001800668 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 (Notice of Proposed Sale) |
| Approx. Transaction Date | 2025-12-15 |
| Transaction Code | N/A |
| Security Type | Common Stock |
| Shares Involved | 3,017 |
| Price Per Share | ~$77.81 (calculated) |
| Total Value | $234,752.77 |
| Shares Owned After | Not specified |
| Ownership Type | Not specified |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $234,752.77 |
| % of Market Cap | 0.0018% |
| Shares Transacted | 3,017 |
| % of Shares Outstanding | 0.0016% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a large-cap company with a $13.10 billion market capitalization, this transaction of ~$235k is financially insignificant.
- Transaction Significance: The sale represents a minuscule percentage of both the market cap and shares outstanding, indicating it is a routine liquidity event for the insider rather than a strategic move.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction size is too small to influence the market. As a proposed sale under a 10b5-1 plan, it is an anticipated and non-discretionary event.
Volume & Sentiment
- Expected Volume Impact: None. The number of shares is trivial compared to daily trading volume.
- Sentiment Indicator: Neutral. The filing does not signal any new information about the company's prospects.
Additional Context
Transaction Notes
- Special Circumstances: The sale is to be made under a Rule 10b5-1 trading plan adopted on May 31, 2023. This indicates the sale was pre-scheduled and not based on recent material non-public information.
- Recent History: The filing discloses that the same insider sold a total of 17,738 shares for ~$1.15 million in the preceding three months, reinforcing a pattern of regular, planned dispositions.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.